[Comparative study of the changes in blood gastrin, insulin, and glucose in non-steroidal anti-inflammatory agent-induced gastroduodenal diseases treated with prostaglandin analogs of the E2 series].
Melloni
G F
GF
Scarazatti
E
E
Fiorenza
A M
AM
Melloni
C F
CF
D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000009:adverse effects*; D001786:Blood Glucose / Q000032:analysis*; D015232:Dinoprostone; D004378:Duodenal Diseases / Q000097:blood* / Q000139:chemically induced / Q000188:drug therapy; D005260:Female; D005755:Gastrins / Q000097:blood*; D006801:Humans; D007328:Insulin / Q000097:blood*; D008297:Male; D008875:Middle Aged; D011458:Prostaglandins E / Q000627:therapeutic use; D013272:Stomach Diseases / Q000097:blood* / Q000139:chemically induced / Q000188:drug therapy
D000894:Anti-Inflammatory Agents, Non-Steroidal; D001786:Blood Glucose; D005755:Gastrins; D007328:Insulin; D011458:Prostaglandins E; D015232:Dinoprostone
Studio comparativo sulle variazioni della gastrinemia, insulinemia, glicemia nelle gastroduodenopatie da FANS in trattamento con analogo prostaglandinico della serie E2.